), a leading global healthcare products company, recently secured
the U.S. Food and Drug Administration (FDA) approval for its
Kangaroo feeding tube with Integrated Real-time Imaging System
(IRIS) technology. Shares of Covidien rose 1.3% since the
announcement to close at $69.90 yesterday.
COVIDIEN PLC (COV): Free Stock Analysis
ENZYMOTEC LTD (ENZY): Free Stock Analysis
OWENS & MINOR (OMI): Free Stock Analysis
ST JUDE MEDICAL (STJ): Free Stock Analysis
To read this article on Zacks.com click here.
The Kangaroo feeding tube introduced by Covidien is the
first-of-its-kind camera-equipped disposable feeding tube. The
device is designed to enhance patient safety by providing visual
support in the placement of small bore feeding tubes - a
procedure which is currently blinded.
The IRIS technology features a camera integrated with a small
bore feeding tube that streams a real-time video back to the
Kangaroo IRIS monitor, thus providing visual information to
clinicians. This information aids them to identify key areas of a
patient's anatomy during the placement of a tube. The system also
enables medical professionals to save images from the live stream
and make notes associated with the image.
Before the Kangaroo feeding tube with IRIS technology became
available, feeding tube placement was often done blindly. Such a
procedure carries the risk of misplacing the feeding tube into
the patient's airway, which can potentially result in a punctured
lung or even death.
The Kangaroo feeding tube with its highly advanced IRIS
technology has given light to an otherwise commonplace, blinded
procedure, steering it to a new direction that facilitates
clinicians to ensure standard quality of care.
In addition to the FDA clearance in the U.S., the Kangaroo
feeding tube with IRIS technology is also approved for use in
Europe, Japan, Canada and Australia. The Kangaroo IRIS monitor is
currently programmed with seven languages: English, Spanish,
French, German, Italian, Portuguese and Dutch.
Currently, Covidien carries a Zacks Rank #3 (Hold). Some
better-ranked stocks in the medical products industry that are
worth a look include
St. Jude Medical Inc.
Owens & Minor Inc.
). Enzymotec carries a Zacks Rank #1 (Strong Buy), while St. Jude
Medical and Owens &Minor retain a Zacks Rank #2 (Buy).